Alpha Crest Capital Management LLC Immuno Gen, Inc. Transaction History

Alpha Crest Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$4.75 - $7.5 $269,325 - $425,250	-56,700 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$5.02 - $6.59 $284,634 - $373,653	56,700 New	56,700 $321,000
Q1 2019 May 10, 2019	SELL	$2.41 - $5.91 $39,283 - $96,333	-16,300 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$3.94 - $9.7 $64,222 - $158,110	16,300 New	16,300 $78,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.